Projeto de célula-T: Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo

Translated title of the contribution: T-Cell project: An international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma

Massimo Federico, Monica Bellei, Emanuela Pesce, Emanuele Zucca, Stefano Pileri, Silvia Montoto, Dennis D. Weisenburger, Thomas Ruediger, Y. H. Ko, Raymond Liang, Pier L. Zinzani, Joseph M. Connors, Francine M. Foss, Steven M. Horwitz, Aaron Polliack, Julie Marie Vose

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5%-10% of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.

Original languagePortuguese
Pages (from-to)21-25
Number of pages5
JournalRevista Brasileira de Hematologia e Hemoterapia
Volume31
Issue numberSUPPL. 2
StatePublished - Nov 2 2009

Fingerprint

Peripheral T-Cell Lymphoma
Observational Studies
Longitudinal Studies
T-Lymphocytes
Lymphoproliferative Disorders
Incidence
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Lymphocytes
Phenotype
Neoplasms

Keywords

  • Chemotherapy
  • Epidemiology
  • Outcome
  • T-cell lymphoma

ASJC Scopus subject areas

  • Hematology

Cite this

Projeto de célula-T : Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo. / Federico, Massimo; Bellei, Monica; Pesce, Emanuela; Zucca, Emanuele; Pileri, Stefano; Montoto, Silvia; Weisenburger, Dennis D.; Ruediger, Thomas; Ko, Y. H.; Liang, Raymond; Zinzani, Pier L.; Connors, Joseph M.; Foss, Francine M.; Horwitz, Steven M.; Polliack, Aaron; Vose, Julie Marie.

In: Revista Brasileira de Hematologia e Hemoterapia, Vol. 31, No. SUPPL. 2, 02.11.2009, p. 21-25.

Research output: Contribution to journalReview article

Federico, M, Bellei, M, Pesce, E, Zucca, E, Pileri, S, Montoto, S, Weisenburger, DD, Ruediger, T, Ko, YH, Liang, R, Zinzani, PL, Connors, JM, Foss, FM, Horwitz, SM, Polliack, A & Vose, JM 2009, 'Projeto de célula-T: Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo', Revista Brasileira de Hematologia e Hemoterapia, vol. 31, no. SUPPL. 2, pp. 21-25.
Federico, Massimo ; Bellei, Monica ; Pesce, Emanuela ; Zucca, Emanuele ; Pileri, Stefano ; Montoto, Silvia ; Weisenburger, Dennis D. ; Ruediger, Thomas ; Ko, Y. H. ; Liang, Raymond ; Zinzani, Pier L. ; Connors, Joseph M. ; Foss, Francine M. ; Horwitz, Steven M. ; Polliack, Aaron ; Vose, Julie Marie. / Projeto de célula-T : Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo. In: Revista Brasileira de Hematologia e Hemoterapia. 2009 ; Vol. 31, No. SUPPL. 2. pp. 21-25.
@article{e1fcea48dfa84afb98e78c94fe8bd070,
title = "Projeto de c{\'e}lula-T: Estudo internacional, longitudinal de pacientes com linfoma de c{\'e}lula-T perif{\'e}rica agressivo",
abstract = "Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5{\%}-10{\%} of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.",
keywords = "Chemotherapy, Epidemiology, Outcome, T-cell lymphoma",
author = "Massimo Federico and Monica Bellei and Emanuela Pesce and Emanuele Zucca and Stefano Pileri and Silvia Montoto and Weisenburger, {Dennis D.} and Thomas Ruediger and Ko, {Y. H.} and Raymond Liang and Zinzani, {Pier L.} and Connors, {Joseph M.} and Foss, {Francine M.} and Horwitz, {Steven M.} and Aaron Polliack and Vose, {Julie Marie}",
year = "2009",
month = "11",
day = "2",
language = "Portuguese",
volume = "31",
pages = "21--25",
journal = "Hematology, Transfusion and Cell Therapy",
issn = "2531-1379",
publisher = "Elsevier Editora Ltda",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Projeto de célula-T

T2 - Estudo internacional, longitudinal de pacientes com linfoma de célula-T periférica agressivo

AU - Federico, Massimo

AU - Bellei, Monica

AU - Pesce, Emanuela

AU - Zucca, Emanuele

AU - Pileri, Stefano

AU - Montoto, Silvia

AU - Weisenburger, Dennis D.

AU - Ruediger, Thomas

AU - Ko, Y. H.

AU - Liang, Raymond

AU - Zinzani, Pier L.

AU - Connors, Joseph M.

AU - Foss, Francine M.

AU - Horwitz, Steven M.

AU - Polliack, Aaron

AU - Vose, Julie Marie

PY - 2009/11/2

Y1 - 2009/11/2

N2 - Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5%-10% of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.

AB - Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are derived from post-thymic lymphoid cells at different stages of differentiation and with different morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse, reflecting the diverse cells from which they can originate and are currently sub-classified using World Health Organization (WHO) 2008 criteria. Peripheral T-Cell Lymphomas account for 5%-10% of all lymphoproliferative disorders in the Western hemisphere, with an overall incidence of 0.5-2 per 100,000 individuals per year, and have a striking epidemiological distribution, with higher incidence in Asia. The clinical features of PTCL are extremely heterogeneous. PTCLs express even more clinical diversity than B-cell non-Hodgkin's lymphomas, and there is a close, though not absolute, relationship between some unusual clinical features and certain histological subtypes.

KW - Chemotherapy

KW - Epidemiology

KW - Outcome

KW - T-cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=70350188837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350188837&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:70350188837

VL - 31

SP - 21

EP - 25

JO - Hematology, Transfusion and Cell Therapy

JF - Hematology, Transfusion and Cell Therapy

SN - 2531-1379

IS - SUPPL. 2

ER -